Indicator disease-guided testing for HIV--the next step for Europe?
HIV should preferably be diagnosed in its earlier stages. To optimize the chances of doing so, HIV testing in patients presenting with one of several indicator diseases and conditions is recommended. Patients presenting with tuberculosis and other AIDS-defining conditions should be tested. Patients with sexually transmitted diseases should be offered an HIV test, as should patients with certain types of cancers and laboratory abnormalities. Governments should consider adopting opt-out testing for pregnant women. These recommendations should be considered for implementation by all types of health professionals across Europe, and audits to study the extent of their being followed, conducted and reported to the European AIDS Clinical Society webpage (http://www.eacs.eu).
Chelsea and Westminster Hospital, London, UK. Brian.Gazzard@chelwest.nhs.uk
B
B
Gazzard
N
N
Clumeck
A
A
d'Arminio Monforte
J D
JD
Lundgren
D015492:AIDS Serodiagnosis / Q000379:methods*; D017088:AIDS-Related Opportunistic Infections / Q000175:diagnosis* / Q000635:transmission; D005060:Europe / Q000453:epidemiology; D005260:Female; D015658:HIV Infections / Q000175:diagnosis* / Q000453:epidemiology / Q000635:transmission; D006291:Health Policy; D006801:Humans; D007154:Immune System Diseases / Q000175:diagnosis*; D008297:Male; D018580:Mandatory Testing; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000175:diagnosis*